204 related articles for article (PubMed ID: 9531184)
1. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM.
Kimura H; Suzuki Y; Gejyo F; Karasawa R; Miyazaki R; Suzuki S; Arakawa M
Am J Kidney Dis; 1998 Apr; 31(4):666-73. PubMed ID: 9531184
[TBL] [Abstract][Full Text] [Related]
2. Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients.
Kwon MK; Rhee SY; Chon S; Oh S; Woo JT; Kim SW; Kim JW; Kim YS; Jeong KH; Lee SH; Lee TW; Ihm CG
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S228-32. PubMed ID: 17624465
[TBL] [Abstract][Full Text] [Related]
3. Relationship between Apolipoprotein E polymorphism and nephropathy in type-2 diabetic patients.
Leiva E; Mujica V; Elematore I; Orrego R; Díaz G; Prieto M; Arredondo M
Diabetes Res Clin Pract; 2007 Nov; 78(2):196-201. PubMed ID: 17481771
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients.
Eto M; Saito M; Okada M; Kume Y; Kawasaki F; Matsuda M; Yoneda M; Matsuki M; Takigami S; Kaku K
Am J Kidney Dis; 2002 Aug; 40(2):243-51. PubMed ID: 12148096
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E polymorphism and the progression of diabetic nephropathy in type 2 diabetes.
Tien KJ; Tu ST; Chou CW; Yang CY; Hsiao JY; Shin SJ; Chen HC; Hsieh MC
Am J Nephrol; 2011; 33(3):231-8. PubMed ID: 21346330
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein e4 allele and the risk of CAD death in type 2 diabetes mellitus with ischaemia electrocardiographic change.
Guang-da X; Xiang-Jiu Y; Lin-Shuang Z; Zhi-Song C; Yu-Sheng H
Diabetes Res Clin Pract; 2005 Jun; 68(3):223-9. PubMed ID: 15936464
[TBL] [Abstract][Full Text] [Related]
7. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan.
Hsieh MC; Lin SR; Yang YC; Chen HC; Lin JN; Shin SJ
J Nephrol; 2002; 15(4):368-73. PubMed ID: 12243365
[TBL] [Abstract][Full Text] [Related]
8. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E polymorphism in 385 patients on renal replacement therapy in Sweden.
Roussos L; Ekström U; Ehle PN; Oqvist B; Floren CH
Scand J Urol Nephrol; 2004; 38(6):504-10. PubMed ID: 15841787
[TBL] [Abstract][Full Text] [Related]
10. Relationship of p22phox C242T polymorphism with nephropathy in type 2 diabetic patients.
Santos KG; Canani LH; Gross JL; Tschiedel B; Souto KE; Roisenberg I
J Nephrol; 2005; 18(6):733-8. PubMed ID: 16358232
[TBL] [Abstract][Full Text] [Related]
11. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM.
Vleming LJ; van der Pijl JW; Lemkes HH; Westendorp RG; Maassen JA; Daha MR; van Es LA; van Kooten C
Clin Nephrol; 1999 Mar; 51(3):133-40. PubMed ID: 10099885
[TBL] [Abstract][Full Text] [Related]
12. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
[TBL] [Abstract][Full Text] [Related]
13. [The relationship of Apo E2 and renal insufficiency lipid levels in NIDDM].
Xiang G; Xia B; He Y
Zhonghua Yi Xue Za Zhi; 1999 May; 79(5):339-41. PubMed ID: 11715472
[TBL] [Abstract][Full Text] [Related]
14. [Insulin receptor substrate-1 and glucose transporter gene polymorphisms in noninsulin-dependent diabetes mellitus].
Liu Z; Guan T; Chen Z
Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):662-5. PubMed ID: 11038788
[TBL] [Abstract][Full Text] [Related]
15. Association between tumour necrosis factor-alpha G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients.
Wang Y; Ng MC; So WY; Ma R; Ko GT; Tong PC; Chan JC
Nephrol Dial Transplant; 2005 Dec; 20(12):2733-8. PubMed ID: 16141456
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation.
Guan J; Zhao HL; Baum L; Sui Y; He L; Wong H; Lai FM; Tong PC; Chan JC
Nephrol Dial Transplant; 2009 Jun; 24(6):1889-95. PubMed ID: 19218599
[TBL] [Abstract][Full Text] [Related]
17. [Genetic-epidemiological studies of apolipoprotein(a) polymorphism and its significance in nephrological diseases and type I diabetes mellitus].
Kronenberg F; Auinger M; Dieplinger H
Acta Med Austriaca; 1999; 26(5):142-7. PubMed ID: 11512190
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
Duman BS; Oztürk M; Yilmazer S; Hatemi H
Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
[TBL] [Abstract][Full Text] [Related]
19. [Polymorphic gene markers of lipid metabolism are associated with diabetic nephropathy in patients with type 1 diabetes mellitus].
Iakunina NIu; Shestakova MV; Voron'ko OE; Vikulova OK; Sevost'ianov KV; Chugunova LA; Shamkhalova MSh; Dedov II; Nosikov VV
Genetika; 2005 Jul; 41(7):931-7. PubMed ID: 16152798
[TBL] [Abstract][Full Text] [Related]
20. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
